Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Ernexa Therapeutics Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names John D. Halpern (filed 2026-05-15).
Who is behind it
Ernexa Therapeutics Inc.: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-05-20).
Officers and directors, each with the role and the filing that names them:
- Sandra Gurrola: Executive Officer (Form D, 2025-04-11)
- Sanjeev Luther: Executive Officer, Director (Form D, 2025-04-11)
- James Bristol: Director (Form D, 2025-04-11)
- Peter Cicala: Director (Form D, 2025-04-11)
- Elena Ratner: Director (Form D, 2025-04-11)
- William Wexler: Director (Form D, 2025-04-11)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-05-20 | Clear Street LLC | 0% |
| Schedule 13G/A, 2026-05-15 | John D. Halpern | 5.6% |
| Schedule 13G/A, 2026-05-15 | Freebird Partners LP | 9.9% |
| Schedule 13G, 2026-05-14 | Bleichroeder LP | 6.86% |
| Schedule 13G, 2026-05-14 | Clear Street LLC | 12.8% |
| Schedule 13G/A, 2026-05-13 | Shameek Konar | 9.7% |
| Schedule 13D/A, 2026-02-17 | Charles Cherington | 34.7% |
| Schedule 13G/A, 2025-12-19 | Freebird Partners LP | 9.9% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-04-11 | $7.25M | $7.25M |
| Form D, 2024-11-14 | $1.14M | $1.14M |
| Form D, 2024-11-14 | $3.89M | $3.89M |
| Form D, 2023-12-20 | $7.79M | $9.19M |
| Form D, 2023-07-26 | $8.71M | $8.71M |
| Form D, 2023-07-26 | $8.71M | $8.71M |
| Form D, 2022-12-16 | $7.71M | $7.71M |
Latest IPO step: Ernexa Therapeutics Inc. amended its IPO registration (S-1/A, 2026-02-05).
IPO filings: S-1/A, 2026-02-05, S-1/A, 2026-02-04, S-1, 2026-02-03, S-1, 2024-11-05; ticker ERNA on Nasdaq Capital Market.
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/ernexa-therapeuticsLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-05-15 · Form D, 2025-04-11 · S-1/A, 2026-02-05 · S-1/A, 2026-02-04
Who owns Ernexa Therapeutics Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/ernexa-therapeutics